Stuttgart, Germany – 9 January, 2015 – Impulse Dynamics announced today the first implantation of its Optimizer IVs device in China. The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses. The implantation took place at the Fu Wei Hospital in Beijing on 30 December 2014 by Prof. Hua Wei, Prof. Zhang Shu, and Associated Professor Fan Xiaohan.
Prof. Wei commented: “We are very pleased with the first implantation in China of the Optimizer system. Chinese patients with heart failure can now benefit from the CCM therapy that is well established in many other countries. Bringing such medical innovations to China will improve the quality of treatment for our patients and benefit our society as a whole”
About the Optimizer and CCM Therapy
The Optimizer IVs device delivers the CCM therapy. It has been successfully launched in Europe and is available in cardiology centers in various countries. The CCM therapy has been implanted in over 2500 patients to date and is the only device therapy available for patients with narrow QRS complex. Impulse Dynamics has completed a vast number of clinical studies, including several randomized controlled trials. The results have been published in over 60 publications in leading medical journals. The Optimizer system is limited to Investigational use only in the United States.
About Impulse Dynamics
Impulse Dynamics N.V. is focused on the development of electrical therapies for the treatment of chronic heart failure. As a global leader in cardiac medical innovation, Impulse Dynamics has operations in the US, Europe, Asia and Australia. For more information please visit www.impulse-dynamics.com
Impulse Dynamics Germany GmbH
Breitwiesenstraße 19
70565 Stuttgart
Tel.: +49 711 220456-0
Fax: +49 711 220456-19
Recent Comments